Show simple item record

dc.contributor.authorAlonso, Eduardo
dc.contributor.authorCalle, Xabier
dc.contributor.authorGurrutxaga Goikoetxea, Ibai ORCID
dc.contributor.authorBeristain Iraola, Andoni
dc.date.accessioned2025-02-06T18:16:31Z
dc.date.available2025-02-06T18:16:31Z
dc.date.issued2024
dc.identifier.citationCollaboration across Disciplines for the Health of People, Animals and Ecosystems : 155-159 (2024)es_ES
dc.identifier.isbn978-1-64368-554-0
dc.identifier.urihttp://hdl.handle.net/10810/72315
dc.description.abstractThe most well-established risk factor for lung cancer (LC) is smoking, responsible for approximately 85% of cases. The Lung Cancer Risk Assessment Tool (LCRAT) is a key advancement in this field, which predicts individual risk based on factors like smoking habits, demographic details, personal and family medical history, and environmental exposures. This paper proposes a model with fewer features that improves state of the art performance, using a simplified stacking ensemble, making it more accessible and easier to implement in routine healthcare practice. The data used in this work were derived from two cohorts in the United States: The National Lung Screening Trial (NLST) and the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Both our model and LCRAT achieve an AUC of 0.799 and 0.782 on test respectively. In terms of percentage of positives, in the 50% of the population, both detect 0.766 and 0.754 of the cases. The ensemble of different survival models enhances robustness by mitigating the weakness of individual models and directly impacts the efficiency of the model, increasing the efficiency and generalizability.es_ES
dc.description.sponsorshipThis work has been founded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement no 101096473. The authors also acknowledge the National Cancer Institute for granting access to the data from the National Lung Screening Trial (NLST) and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).es_ES
dc.language.isoenges_ES
dc.publisherIOS Presses_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/101096473es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.titleSurvival Stacking Ensemble Model for Lung Cancer Risk Predictiones_ES
dc.typeinfo:eu-repo/semantics/bookPartes_ES
dc.rights.holder© 2024 The Authors. This article is published online with Open Access by IOS Press and distributed under the terms of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0)es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://ebooks.iospress.nl/doi/10.3233/SHTI241083es_ES
dc.identifier.doi10.3233/SHTI241083
dc.contributor.funderEuropean Commission
dc.departamentoesArquitectura y Tecnología de Computadoreses_ES
dc.departamentoeuKonputagailuen Arkitektura eta Teknologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 The Authors.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0)
Except where otherwise noted, this item's license is described as © 2024 The Authors. This article is published online with Open Access by IOS Press and distributed under the terms of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0)